Jun 11, 2020 / 03:40PM GMT
Margaret Kaczor - William Blair - Analyst
Good morning, everyone. My name is Margaret Kaczor and I am the research analyst here at William Blair & Company who covers Neuronetics. I am required to tell you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
Thank you to all for making this a very successful week -- showing up for a three. Very happy to have Neuronetics here. Just as a little bit of a background, Neuronetics is the manufacturer of the NeuroStar treatment, which is used in the treatment of major depressive disorder.
Frankly the stock struggled over the last year or so as growth has slowed. Then following that slowdown management started to change its corporate strategy to better address that [group] environment that we're seeing. So, we will walk through the background and the history with Steve Furlong, Neuronetics' CFO and member of the Interim Office of the President; as well as Andy Macan, SVP, General Counsel as well as second member of the Interim Office of the President.
Long story short,
Neuronetics Inc at William Blair Growth Stock Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers